• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    AstraZeneca PLC - American Depositary Shares (NY:AZN)

    182.52 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, May 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 13,091
    Open 182.52
    Bid (Size) 181.07 (100)
    Ask (Size) 181.16 (200)
    Prev. Close 182.52
    Today's Range 182.52 - 182.52
    52wk Range 180.00 - 212.71
    Shares Outstanding N/A
    Dividend Yield 0.51%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    This Low-Cost ETF Holds Almost 8,800 Stocks Across Both Developed and Emerging Markets. Here's Why It's a Compelling Long-Term Core Holding ↗
    If you're looking for diversification and value, here's a good ETF to check out. 
    Via The Motley Fool
    Topics ETFs
    News headline image
    The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat ↗
    Via MarketBeat

    Performance

    YTD
    -3.1%
    -3.1%
    1 Month
    -9.1%
    -9.1%
    3 Month
    -2.5%
    -2.5%
    6 Month
    -3.1%
    -3.1%
    1 Year
    -3.1%
    -3.1%

    More News

    Read More
    News headline image
    TRUQAP® (capivasertib) recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer
    From AstraZeneca
    Via Business Wire
    News headline image
    AstraZeneca results: Q1 2026
    From AstraZeneca
    Via Business Wire
    AstraZeneca (NYSE:AZN) Passes the Caviar Cruise Quality Screen with Strong Profitability and Growth ↗
    Via Chartmill
    News headline image
    BREZTRI approved in the US for asthma as first and only triple therapy for patients 12 years of age and older
    From AstraZeneca
    Via Business Wire
    News headline image
    SAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus
    From AstraZeneca
    Via Business Wire
    News headline image
    Is Bristol Myers Squibb the Best Bargain in Big Pharma? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Pictet Loads Up MercadoLibre With 3,500 Shares Worth $6.8 Million ↗
    Via The Motley Fool
    News headline image
    Could AbbVie Crash Lilly's Weight‑Loss Party? ↗
    Via The Motley Fool
    News headline image
    Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity
    Via MarketMinute
    Topics Economy
    News headline image
    Gilead Sciences Solidifies Oncology Future with $5 Billion Acquisition of ADC Innovator Tubulis
    Via MarketMinute
    Topics Bonds
    News headline image
    Trump Issues Landmark Executive Order: 100% Tariffs on Imported Patented Drugs to Force Onshoring
    Via MarketMinute
    Topics Economy Government Lawsuit
    News headline image
    Merck’s Oncology Empire Expands: Keytruda Secures Pivotal European Commission Approval for Recurrent Ovarian Cancer
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl) improves PFS in early liver cancer
    From AstraZeneca
    Via Business Wire
    News headline image
    Corcept Therapeutics Outperforms: How a Surprise FDA Approval Ignited a Late-March Rally
    Via MarketMinute
    Topics ETFs Intellectual Property Stocks
    News headline image
    Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
    Via Finterra
    Topics Initial Public Offering
    News headline image
    AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD
    From AstraZeneca
    Via Business Wire
    News headline image
    Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience
    Via Finterra
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    The Great Unbundling: How AI’s Insatiable Hunger is Driving a Corporate Divestiture Gold Rush
    Via MarketMinute
    Topics Artificial Intelligence Economy
    News headline image
    Could This International ETF Be One of the Best Investments of 2026? ↗
    Via The Motley Fool
    Topics ETFs
    News headline image
    The 'Sentiment Trap': Why Beating Earnings Is No Longer Enough in the Age of AI Sentiment Analysis
    Via MarketMinute
    Topics Artificial Intelligence Earnings Regulatory Compliance
    News headline image
    The Billion-Dollar Divide: How "Megadeals" Are Defining a K-Shaped M&A Market in 2026
    Via MarketMinute
    Topics Artificial Intelligence Economy Energy
    News headline image
    Pfizer (PFE) 2026 Research Feature: The High-Stakes Pivot to Oncology and Obesity
    Via Finterra
    Topics Economy Intellectual Property Lawsuit

    Frequently Asked Questions

    Is AstraZeneca PLC - American Depositary Shares publicly traded?
    Yes, AstraZeneca PLC - American Depositary Shares is publicly traded.
    What exchange does AstraZeneca PLC - American Depositary Shares trade on?
    AstraZeneca PLC - American Depositary Shares trades on the New York Stock Exchange
    What is the ticker symbol for AstraZeneca PLC - American Depositary Shares?
    The ticker symbol for AstraZeneca PLC - American Depositary Shares is AZN on the New York Stock Exchange
    What is the current price of AstraZeneca PLC - American Depositary Shares?
    The current price of AstraZeneca PLC - American Depositary Shares is 182.52
    When was AstraZeneca PLC - American Depositary Shares last traded?
    The last trade of AstraZeneca PLC - American Depositary Shares was at 05/07/26 07:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.